Bayer | Benzinga
One of the largest SPACs seeking a target could be nearing a $20 billion deal to bring one of the largest privately-held biotechnology companies public. The SPAC Rumor: Bloomberg reports Ginkgo Bioworks is in talks with Soaring Eagle Acquisition Corp (NASDAQ: SRNGU), a SPAC led by Harry Sloan and... Read More...
Source: benzinga.com